Artificial Intelligence for Clinical Trials in Retinal Diseases

Time: 11:30 am
day: Conference Day Two


  • Identifying challenges and hurdles in clinical trials for drug development that can be positively impacted by AI-based tools
  • Using AI-based tools to extract scientific insights, enable better disease characterization, and predict disease progression
  • Considerations on implementation of AI-based tools in clinical trials